Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FXANV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $104,861
Award facts
- Contract value 100% obligated
- $104,861.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $104,861.34 delivery order to AmerisourceBergen Drug Corp for the supply of Stelara 45 mg/0.5 mL syringes on a firm fixed-price basis. The order was competitively awarded without set-aside designation and is scheduled for completion by September 29, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. Stelara (ustekinumab) is a biologic immunosuppressant medication commonly used to treat autoimmune conditions, and this delivery order represents a specific pharmaceutical procurement to support federal healthcare needs, likely for military or veteran medical systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor in the federal medical supply chain, AmerisourceBergen's portfolio includes specialty medications, vaccines, generic and brand-name drugs, and medical devices across multiple therapeutic domains, positioning it as a key supplier for Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FXANV?
SPE2DB25FXANV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FXANV worth?
The government has obligated $104,861 on SPE2DB25FXANV.
Is contract SPE2DB25FXANV an order under another contract?
Yes. SPE2DB25FXANV is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FXANV competed?
The extent of competition for SPE2DB25FXANV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award